Lansoprazolo Mylan Generics Italia

Lansoprazole, the active ingredient in Lansoprazolo Mylan Generics Italia, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid secretion and is employed to treat acid‑related disorders such as gastro‑oesophageal reflux disease, erosive oesophagitis, peptic ulcer disease, and as part of Helicobacter pylori eradication regimens.

GNH USA supplies Lansoprazolo Mylan Generics Italia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole is a proton pump inhibitor used to manage conditions caused by excess gastric acid.

- Gastro‑oesophageal reflux disease: reduces acid exposure and promotes healing of the oesophageal lining. - Erosive oesophagitis: facilitates mucosal repair by lowering gastric acidity. - Peptic ulcer disease: promotes ulcer healing and prevents recurrence. - Helicobacter pylori eradication: used in combination therapy to increase eradication rates.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: loose stools occurring intermittently. - Abdominal pain: discomfort or cramping in the stomach area. - Nausea: feeling of queasiness without vomiting. - Flatulence: increased intestinal gas. - Constipation: infrequent or hard stools.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or anaphylaxis. - Clostridioides difficile infection: persistent diarrhoea with abdominal pain. - Elevated liver enzymes: signs of hepatic stress. - Hypomagnesemia: low magnesium levels causing muscle cramps. - Stevens‑Johnson syndrome: severe skin reactions. - Interstitial nephritis: kidney inflammation presenting with reduced urine output.

Before initiating therapy, consider the following precautions: - Assess renal function: adjust use in patients with severe renal impairment. - Monitor magnesium levels: prolonged use may lead to hypomagnesemia. - Use caution in hepatic disease: liver dysfunction may affect drug metabolism. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Review concomitant medications: potential for drug‑drug interactions. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Lansoprazole can affect the absorption and metabolism of several drugs.

Major Interactions (Avoid): - Ketoconazole: reduced antifungal efficacy due to decreased absorption. - Atazanavir: lowered antiviral levels, compromising HIV therapy. - Clarithromycin: increased risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - Warfarin: enhanced anticoagulant effect, monitor INR. - Phenytoin: reduced anticonvulsant levels, watch seizure control. - Digoxin: increased serum concentration, monitor for toxicity. - Methotrexate: higher exposure may increase toxicity. - HIV protease inhibitors: altered plasma concentrations, adjust dosing as needed.